rs193922639

Variant summary

Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2

The NM_001943.5(DSG2):​c.1174G>A​(p.Val392Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,614,094 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 13 hom. )

Consequence

DSG2
NM_001943.5 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:17

Conservation

PhyloP100: 1.68
Variant links:
Genes affected
DSG2 (HGNC:3049): (desmoglein 2) This gene encodes a member of the desmoglein family and cadherin cell adhesion molecule superfamily of proteins. Desmogleins are calcium-binding transmembrane glycoprotein components of desmosomes, cell-cell junctions between epithelial, myocardial, and other cell types. The encoded preproprotein is proteolytically processed to generate the mature glycoprotein. This gene is present in a gene cluster with other desmoglein gene family members on chromosome 18. Mutations in this gene have been associated with arrhythmogenic right ventricular dysplasia, familial, 10. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -11 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07768899).
BP6
Variant 18-31531146-G-A is Benign according to our data. Variant chr18-31531146-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 36009.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=5, Benign=7, Uncertain_significance=1}. Variant chr18-31531146-G-A is described in Lovd as [Benign]. Variant chr18-31531146-G-A is described in Lovd as [Likely_benign]. Variant chr18-31531146-G-A is described in Lovd as [Pathogenic]. Variant chr18-31531146-G-A is described in Lovd as [Pathogenic].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00164 (249/152256) while in subpopulation SAS AF= 0.00436 (21/4822). AF 95% confidence interval is 0.00292. There are 1 homozygotes in gnomad4. There are 116 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 249 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DSG2NM_001943.5 linkuse as main transcriptc.1174G>A p.Val392Ile missense_variant 9/15 ENST00000261590.13 NP_001934.2
DSG2XM_047437315.1 linkuse as main transcriptc.640G>A p.Val214Ile missense_variant 10/16 XP_047293271.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DSG2ENST00000261590.13 linkuse as main transcriptc.1174G>A p.Val392Ile missense_variant 9/151 NM_001943.5 ENSP00000261590 P1
DSG2ENST00000683614.2 linkuse as main transcriptn.1005G>A non_coding_transcript_exon_variant 7/7

Frequencies

GnomAD3 genomes
AF:
0.00164
AC:
249
AN:
152138
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00435
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00254
Gnomad OTH
AF:
0.000955
GnomAD3 exomes
AF:
0.00219
AC:
545
AN:
249420
Hom.:
3
AF XY:
0.00243
AC XY:
329
AN XY:
135312
show subpopulations
Gnomad AFR exome
AF:
0.000839
Gnomad AMR exome
AF:
0.000521
Gnomad ASJ exome
AF:
0.000596
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00608
Gnomad FIN exome
AF:
0.000835
Gnomad NFE exome
AF:
0.00259
Gnomad OTH exome
AF:
0.00182
GnomAD4 exome
AF:
0.00273
AC:
3984
AN:
1461838
Hom.:
13
Cov.:
31
AF XY:
0.00286
AC XY:
2077
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.000329
Gnomad4 AMR exome
AF:
0.000514
Gnomad4 ASJ exome
AF:
0.000344
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00625
Gnomad4 FIN exome
AF:
0.00129
Gnomad4 NFE exome
AF:
0.00288
Gnomad4 OTH exome
AF:
0.00197
GnomAD4 genome
AF:
0.00164
AC:
249
AN:
152256
Hom.:
1
Cov.:
32
AF XY:
0.00156
AC XY:
116
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.000481
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00436
Gnomad4 FIN
AF:
0.00104
Gnomad4 NFE
AF:
0.00254
Gnomad4 OTH
AF:
0.000945
Alfa
AF:
0.00249
Hom.:
1
Bravo
AF:
0.00142
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000533
AC:
2
ESP6500EA
AF:
0.00207
AC:
17
ExAC
AF:
0.00257
AC:
310
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00207
EpiControl
AF:
0.00196

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:17
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:6
Benign, criteria provided, single submitterclinical testingGeneDxSep 08, 2020This variant is associated with the following publications: (PMID: 23812740, 26899768, 25637381, 23299917, 21636032, 24070718, 17105751, 20031616, 20129281, 20829228, 21606390, 21859740, 21606396, 21723241, 23071725, 23396983, 24436435, 24055113, 26138720, 26681313, 27153395, 25985138, 28255936, 29062102, 30885746) -
Benign, criteria provided, single submitterclinical testingMendelicsAug 22, 2023- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024DSG2: BP4, BS2 -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJun 28, 2023- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not specified Benign:5
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 03, 2015p.Val392Ile in exon 9 of DSG2: This variant has been reported in many individual s with diverse presentations (ARVC, LQTS1, LDAC, DCM: Syrris 2007, Bhuiyan 2009, Bauce 2010, Klauke 2010, Quarta 2011, Cox 2011, Bauce 2011, Garcia-Parva 2011, LMM unpublished data). However, this variant has also been identified in 0.7% (1 11/16510) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org;dbSNP rs193922639). In addition, valine (Val) at position 392 is poorly conserved in evolution and the variant is present in two species (including 1 mammal), suggesting that a change to this position may be t olerated. In summary, this variant is likely benign but a modifying role cannot be excluded. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 26, 2019Variant summary: DSG2 c.1174G>A (p.Val392Ile) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0022 in 249420 control chromosomes in the gnomAD database, including 3 homozygotes. The observed variant frequency is approximately 200 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSG2 causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. Though c.1174G>A has been reported in the literature in individuals affected with ARVC/D, LQTS and DCM, including families showing incomplete co-segregation with disease, in addition, multiple co-occurrences with other pathogenic variants have been noted (PKP2 c.148_151delACAG (p.Thr50fsX61), Bauce_2010, Rigato_2013; PKP2 c.235C>T (p.Arg79X), Cox _2011), providing supporting evidence for a benign role. Publication also reported experimental evidence evaluating an impact on protein function, and demonstrated no damaging effect of this variant (Gaertner_2012, Dieding_2017). Six other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as Benign (2x), Likely benign (3x) or VUS (1x). Based on the evidence outlined above, the variant was classified as benign. -
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1Benign:1
Likely benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Uncertain significance, criteria provided, single submitterresearchCSER _CC_NCGL, University of WashingtonJun 01, 2014Low GERP score may suggest that this variant may belong in a lower pathogenicity class -
Cardiomyopathy Benign:2
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioJul 25, 2018- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJun 11, 2018- -
Arrhythmogenic right ventricular dysplasia 10 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Arrhythmogenic right ventricular dysplasia 1 Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart InstituteJul 25, 2019- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 08, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
15
DANN
Benign
0.96
DEOGEN2
Benign
0.11
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.0065
N
LIST_S2
Benign
0.48
T
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.078
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
2.5e-11
A
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.51
N
REVEL
Benign
0.27
Sift
Uncertain
0.017
D
Sift4G
Uncertain
0.032
D
Polyphen
0.0080
B
Vest4
0.082
MVP
0.35
MPC
0.059
ClinPred
0.0093
T
GERP RS
0.98
Varity_R
0.071
gMVP
0.28

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs193922639; hg19: chr18-29111109; COSMIC: COSV99853070; API